Guangdong Taienkang Pharmaceutical Co., Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 782.8 million compared to CNY 653.65 million a year ago. Revenue was CNY 783.48 million compared to CNY 653.65 million a year ago.

Net income was CNY 174.61 million compared to CNY 120.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.4389 compared to CNY 0.3778 a year ago. Diluted earnings per share from continuing operations was CNY 0.4389 compared to CNY 0.3778 a year ago.